Hi Sector.
Thank you for posting that. It is always good to point out what happens when a therapy/ medicine fails to do what it claims. Otherwise a waste on resources and tax payers hard earned cash.
The result seems fair for all.( Reimbursement if fails to work)
I would expect similar if MSB Rem-l made similar claims and only achieved similar outcomes.
Im really happy that Silviu has gone down the right road of FDA approval. I’m confident that he is well aware of all potential outcomes, but is confident that MSB has what it takes.
i suppose we will find out soon enough
MSB Trading - 2020, page-12913
-
- There are more pages in this discussion • 10,248 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |